Skip to main content

Respirable Advanced Therapeutics for Cystic Fibrosis & other Lung Diseases

Description du projet

Exosome-mediated gene therapy for cystic fibrosis

Appel à propositions

H2020-SMEInst-2018-2020-1
Voir d’autres projets de cet appel

Régime de financement

SME-1 - SME instrument phase 1

Coordinateur

OMNISPIRANT LIMITED
Adresse
Rathronan
E91D9N2 Clonmel Tipperary
Irlande
Type d’activité
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Contribution de l’UE
€ 50 000